Position in SEER
as of Mar 31, 2026
· filed May 14, 2026
Position Value
$58,766
-$5,944 QoQ
Shares Held
34,980
+6.5% QoQ
Ownership
0.064%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2022
9 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SEER Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026ALGERT GLOBAL LLC holds $437,724,004 across 106 Biotechnology names. SEER ranks #105 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ROIV |
Roivant Sciences Ltd.
|
827,454 | $22,920,475 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
135,460 | $22,895,449 | |
| 3 | SNDX |
Syndax Pharmaceuticals Inc
|
928,568 | $21,691,348 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
363,984 | $21,151,110 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
283,921 | $21,083,973 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
264,200 | $15,363,230 | |
| 7 | MRNA |
Moderna, Inc.
|
237,418 | $12,060,834 | |
| 8 | VRDN |
Viridian Therapeutics, Inc.\DE
|
563,999 | $11,031,820 |
All Filings in SEER
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $58,766 | 34,980 | Shares | Sole | 2026-05-14 | |
| 2024-09-30 | $64,710 | 32,848 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $18,110 | 10,780 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $20,482 | 10,780 | Shares | Sole | 2024-05-15 | |
| 2023-06-30 | $135,363 | 31,701 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $464,913 | 120,444 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $941,844 | 162,387 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $290,652 | 37,552 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $155,461 | 17,370 | Shares | Sole | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||